The Effect of Dexmedetomidine on Kidney Function in EVAR
NCT ID: NCT04766047
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2021-08-30
2024-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy
NCT02137863
RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
NCT03789695
Heme Arginate in Cardiac Surgery Patients
NCT02142699
Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
NCT00634491
The Effect of Remote Ischemic Preconditioning on Elective Percutaneous Coronary Intervention in Diabetic Nephropathy
NCT02329444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DEXMEDETOMIDINE AND AKI
The patients of the group undergoing EVAR under general anesthesia will receive dexmedetomidine intraoperatively.
Dexmedetomidine
Administration of dexmedetomidine intraoperatively
CONTROL AND AKI
The patients of the group undergoing EVAR under general anesthesia will not receive dexmedetomidine intraoperatively.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
Administration of dexmedetomidine intraoperatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adult patients 18- 85 years old
* American society of anesthesiologists (ASA) physical status I - IV
Exclusion Criteria
* GFR \< 50ml/mim
* Bradyarrhythmia \<50/min
* Hemodynamic instability
* Known allergy to Dexmedetomidine
* Severe hepatic insufficiency
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Thessaly
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elena Arnaoutoglou
Professor of anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eleni Arnaoutoglou, MD, PhD
Role: STUDY_CHAIR
University of Thessaly
Konstantinos Stamoulis, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Larissa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univeristy of Thessaly
Larissa, Thessaly, Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dexmedetomidine in EVAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.